MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Awareness and Implementation of Advanced Care Planning in Patients with Neurodegenerative Diseases

T. Osada, M. Ohira, K. Kimura, T. Sano, M. Takao (Kodaira, Tokyo, Japan)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Palliative Care

Objective: This study aims to evaluate the awareness and implementation of advanced care planning (ACP) in patients with neurodegenerative diseases in Japan.

Background: Although ACP may be important for providing appropriate care for patient’s dignity, there was little information of awareness and implementation of ACP of patients with neurodegenerative conditions in Japan. The aim of this study is to clarify the understanding of ACP of the patients having neurodegenerative diseases.

Method: An anonymous questionnaire was distributed to 150 patients with neurodegenerative diseases hospitalized to our hospital from August 2024 to January 2025. The questionnaire included demographic data, diagnosis, disease duration, views on end-of-life care, understanding of ACP, and  written documentation of ACP.

Results: The questionnaires were collected from 83 patients. Respondents’ mean age was 69.2 ±9.0years and their sex was 41 male, 38 female, and 3 unspecified. Their diagnoses were 62 with Parkinson’s disease, 7 with multiple system atrophy, 4 with spinocerebellar degeneration, 2 with progressive supranuclear palsy, 2 with spinocerebellar ataxia (SCA)3, 2 with SCA6, 1 with corticobasal degeneration, 1 with SCA31, and 1 with unknown disease. Mean duration of disease  was 5.3 years. 44 patients answered that they had desire about their end-of-life care. Three and 16 patients had experiences of “extensive discussions” and “some discussions” with their families about ACP, respectively. 60 patients have never discussions about it. 59 patients agreed with the idea that having a written document about ACP should be implemented as possible. Among them, only 4 had already made them. Regarding awareness of ACP, 63 patients were “unaware,” 15 had “heard of it but knew little,” and 3 had “good knowledge. After explaining the purpose of ACP, 65 patients said they agreed, 1 disagreed and 13 were unsure about ACP.

Conclusion: Compared to previous report, ACP were not so common in Japan as in other western countries. Although many patients were in favor of discussing and planning their end-of-life care, ratio of understanding of ACP in patients turned out low. Only a few actually made written directives for ACP. To help patients with neurodegenerative diseases to reveal their desire about end-of-life care, it is important to foster knowledge about APC in patients and active implement of ACP.

To cite this abstract in AMA style:

T. Osada, M. Ohira, K. Kimura, T. Sano, M. Takao. Awareness and Implementation of Advanced Care Planning in Patients with Neurodegenerative Diseases [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/awareness-and-implementation-of-advanced-care-planning-in-patients-with-neurodegenerative-diseases/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/awareness-and-implementation-of-advanced-care-planning-in-patients-with-neurodegenerative-diseases/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley